Articles related to ALERTS/WARNINGS/ADVISEMENT

“An ounce of prevention is worth a pound of cure, so if this new advisory leads to a decrease in alcohol consumption, I think we will start to see a decline in certain cancers and cancer-related death in the next 10 years.”

Monthly hepatic monitoring becomes mandatory for the first three months of Veozah therapy, marking a significant shift in safety protocols for menopausal vasomotor symptom management.

The CDC investigation revealed that the 65 people who contracted Salmonella from the outbreak ranged from 2 to 88 years old, highlighting the wide demographic susceptibility to foodborne illnesses.

Recent findings indicate that 65% of tested popular bandage brands contain potentially harmful PFAS, known for their persistence in the environment and association with serious health conditions such as thyroid disorders and infertility.

With a significant rise in meningococcal disease cases in 2023 and continuing into 2024, physicians must be alert for non-traditional symptoms such as septic arthritis and bacteremia to ensure timely and effective patient management.

The FDA’s recent warnings about high-concentration lidocaine in OTC analgesics spotlight a significant health risk, emphasizing the need for healthcare professionals to guide patients in choosing safe and approved pain relief options.